Terms of the agreement include upfront and milestone payments as well as ongoing royalties. In addition to the License Agreement, the two companies have agreed to a Letter of Intent under which DxNA ...
St. George, UT-based molecular diagnostics firm DxNA is slated to acquire PathoGene, a company that develops PCR-based infectious disease diagnostics and is headquartered in Flagstaff, AZ, for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback